Loading...

Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature

Many patients with depression fail to derive sufficient benefit from available treatment options, with up to a third never reaching remission despite multiple trials of appropriate treatment. Novel antidepressant agents are needed, and drugs targeting nicotinic acetylcholine receptors (nAChRs) appea...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacology (Berl)
Main Authors: Philip, Noah S., Carpenter, Linda L., Tyrka, Audrey R., Price, Lawrence H.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5316481/
https://ncbi.nlm.nih.gov/pubmed/20614106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-010-1932-6
Tags: Add Tag
No Tags, Be the first to tag this record!